How long does it take for ustekinumab to be effective in treating psoriasis?

Ustekinumab is a drug that targets interleukin-12 (IL-12 ) and interleukin-23 (IL-23) monoclonal antibodies, which are widely used in the treatment of patients with moderate to severe psoriasis (psoriasis). It reduces the inflammatory response and abnormal keratinization of the skin by inhibiting the signaling pathways of these two cytokines, thereby improving the symptoms of psoriasis. Patients are generally concerned about how long it will take to see significant effects after using ustekinumab.

According to clinical trial data, most patients can begin to experience improvement in symptoms, such as reduction of erythema, reduction of scales and relief of itching, within 4 to 6 weeks after the first injection. In some patients, the lesions were significantly reduced and the skin condition was significantly improved within the first 1 month. Ustekinumab has a faster onset of action than some traditional treatments, which is one of the reasons why it is widely recommended.

For some patients with severe illness or special constitution, it may take longer to observe the effect. It is usually recommended to continue taking the drug for at least 12 weeks to evaluate the overall treatment effect. Doctors will adjust subsequent medication regimens based on the patient's specific response in order to obtain the best efficacy and sustained disease control. In addition, regular treatment and regular follow-up are also very important to ensure stable efficacy.

In general, ustekinumab usually starts to be effective in the treatment of psoriasis in about one and a half months, and the vast majority of patients can achieve good symptom relief within 3 months. Patients should remain patient, follow the doctor's instructions, and cooperate with lifestyle adjustments and skin care to obtain the best treatment effect and quality of life.

Reference materials:https://www.drugs.com